variables | Total N = 10,164 | vaccinated at least one dose (N = 10,034) | Unvaccinated (N = 130) | ||
---|---|---|---|---|---|
willing to vaccinate (N = 5,700) | hesitant to vaccinate (N = 4,334) | willing to vaccinate (N = 32) | hesitant to vaccinate (N = 98) | ||
Gender | |||||
 M²¹±ô±ð | 3,273 | 1,873 | 1,359 | 11 | 30 |
(32.2%) | (58.0%) | (42.0%) | (26.8%) | (73.2%) | |
 F±ð³¾²¹±ô±ð | 6,891 | 3,827 | 2,975 | 21 | 68 |
(67.8%) | (56.3%) | (43.7%) | (23.6%) | (76.4%) | |
Age, mean ± SD | 29.09 ±â¶Ä‰12.59 | 28.70 ±â¶Ä‰12.74 | 29.42 ±â¶Ä‰12.27 | 35.84 ±â¶Ä‰15.35 | 34.94 ±â¶Ä‰14.22 |
Age | |||||
 18–59 | 9,902 | 5,529 | 4,253 | 28 | 92 |
(97.4%) | (56.5%) | (43.5%) | (23.3%) | (76.7%) | |
 60 and above | 262 | 171 | 81 | 4 | 6 |
(2.6%) | (67.9%) | (32.1%) | (40.0%) | (60.0%) | |
Region | |||||
 C±ð²Ô³Ù°ù²¹±ô | 1,712 | 918 | 767 | 7 | 20 |
(16.8%) | (54.5%) | (45.5%) | (25.9%) | (74.1%) | |
 N´Ç°ù³Ù³ó | 3,991 | 2,323 | 1,636 | 8 | 24 |
(39.3%) | (58.7%) | (41.3%) | (25.0%) | (75.0%) | |
 E²¹²õ³Ù | 387 | 210 | 167 | 0 | 10 |
(3.8%) | (55.7%) | (44.3%) | (0.0%) | (100.0%) | |
â€Çȴdzܳٳó | 1,371 | 836 | 521 | 3 | 11 |
(13.5%) | (61.6%) | (38.4%) | (21.4%) | (78.6%) | |
 W±ð²õ³Ù | 2,703 | 1,413 | 1,243 | 14 | 33 |
(26.6%) | (53.2%) | (46.8%) | (29.8%) | (70.2%) | |
Education level | |||||
 Primary school and below | 110 | 64 | 41 | 2 | 3 |
(1.1%) | (61.0%) | (39.0%) | (40.0%) | (60.0%) | |
 Junior high school | 376 | 212 | 161 | 0 | 3 |
(3.7%) | (56.8%) | (43.2%) | (0.0%) | (100.0%) | |
 Senior high school | 926 | 483 | 432 | 3 | 8 |
(9.1%) | (52.8%) | (47.2%) | (27.3%) | (72.7%) | |
 University or college | 7,550 | 4,287 | 3,178 | 22 | 63 |
(74.3%) | (57.4%) | (42.6%) | (25.9%) | (74.1%) | |
 Graduate degree | 1,202 | 654 | 522 | 5 | 21 |
(11.8%) | (55.6%) | (44.4%) | (19.2%) | (80.8%) | |
Student status | |||||
 N´Ç | 4,818 | 2,489 | 2,231 | 24 | 74 |
(47.4%) | (52.7%) | (47.3%) | (24.5%) | (75.5%) | |
 Y±ð²õ | 5,346 | 3,211 | 2,103 | 8 | 24 |
(52.6%) | (60.4%) | (39.6%) | (25.0%) | (75.0%) | |
Monthly income (CNY) | |||||
 &±ô³Ù; 5,000 | 7,298 | 4,212 | 3,020 | 16 | 50 |
(71.8%) | (58.2%) | (41.8%) | (24.2%) | (75.8%) | |
 5,000–9,999 | 2,074 | 1,105 | 930 | 9 | 30 |
(20.4%) | (54.3%) | (45.7%) | (23.1%) | (76.9%) | |
 10,000–29,999 | 629 | 309 | 303 | 5 | 12 |
(6.2%) | (50.5%) | (49.5%) | (29.4%) | (70.6%) | |
 ≥ 30,000 | 163 | 74 | 81 | 2 | 6 |
(1.6%) | (47.7%) | (52.3%) | (25.0%) | (75.0%) | |
Cohabitation status | |||||
â€Çã±ô´Ç²Ô±ð | 717 | 383 | 320 | 2 | 12 |
(7.1%) | (54.5%) | (45.5%) | (14.3%) | (85.7%) | |
 C´Ç³ó²¹²ú¾±³Ù²¹³Ù¾±´Ç²Ô | 9,447 | 5,317 | 4,014 | 30 | 86 |
(92.9%) | (57.0%) | (43.0%) | (25.9%) | (74.1%) | |
Chronic disease | |||||
 N´Ç | 9,231 | 5,226 | 3,905 | 26 | 74 |
(90.8%) | (57.2%) | (42.8%) | (26.0%) | (74.0%) | |
 Y±ð²õ | 933 | 474 | 429 | 6 | 24 |
(9.2%) | (52.5%) | (47.5%) | (20.0%) | (80.0%) | |
Covid-19 infection status | |||||
 U²Ô¾±²Ô´Ú±ð³¦³Ù±ð»å | 1,464 | 886 | 550 | 7 | 21 |
(14.4%) | (61.7%) | (38.3%) | (25.0%) | (75.0%) | |
 During infection | 449 | 207 | 232 | 1 | 9 |
(4.4%) | (47.2%) | (52.8%) | (10.0%) | (90.0%) | |
 R±ð³¦´Ç±¹±ð°ù±ð»å | 7,070 | 3,973 | 3,018 | 19 | 60 |
(69.6%) | (56.8%) | (43.2%) | (24.1%) | (75.9%) | |
 U²Ô°ì²Ô´Ç·É²Ô | 1,181 | 634 | 534 | 5 | 8 |
(11.6%) | (54.3%) | (45.7%) | (38.5%) | (61.5%) | |
Depressive symptoms | |||||
 M¾±²Ô¾±³¾²¹±ô | 3,931 | 2,514 | 1,367 | 16 | 34 |
(38.7%) | (64.8%) | (35.2%) | (32.0%) | (68.0%) | |
 M¾±±ô»å | 3,583 | 1,977 | 1,568 | 11 | 27 |
(35.2%) | (55.8%) | (44.2%) | (28.9%) | (71.1%) | |
 M´Ç»å±ð°ù²¹³Ù±ð | 1,372 | 660 | 693 | 2 | 17 |
(13.5%) | (48.8%) | (51.2%) | (10.5%) | (89.5%) | |
â€Çȱ𱹱ð°ù±ð | 1,278 | 549 | 706 | 3 | 20 |
(12.6%) | (43.7%) | (56.3%) | (13.0%) | (87.0%) | |
Anxiety symptoms | |||||
 M¾±²Ô¾±³¾²¹±ô | 6,006 | 3,684 | 2,251 | 21 | 50 |
(59.1%) | (62.1%) | (37.9%) | (29.6%) | (70.4%) | |
 M¾±±ô»å | 2,701 | 1,367 | 1,301 | 10 | 23 |
(26.6%) | (51.2%) | (48.8%) | (30.3%) | (69.7%) | |
 M´Ç»å±ð°ù²¹³Ù±ð | 1,000 | 444 | 539 | 1 | 16 |
(9.8%) | (45.2%) | (54.8%) | (5.9%) | (94.1%) | |
â€Çȱ𱹱ð°ù±ð | 457 | 205 | 243 | 0 | 9 |
(4.5%) | (45.8%) | (54.2%) | (0.0%) | (100.0%) | |
PTSD symptoms | |||||
 N´Ç | 6,637 | 3,975 | 2,585 | 22 | 55 |
(65.3%) | (60.6%) | (39.4%) | (28.6%) | (71.4%) | |
 Y±ð²õ | 3,527 | 1,725 | 1,749 | 10 | 43 |
(34.7%) | (49.7%) | (50.3%) | (18.9%) | (81.1%) | |
Have received other vaccines in the past five years | |||||
 N´Ç | 7,747 | 4,325 | 3,319 | 26 | 77 |
(76.2%) | (56.6%) | (43.4%) | (25.2%) | (74.8%) | |
 Y±ð²õ | 2,417 | 1,375 | 1,015 | 6 | 21 |
(23.8%) | (57.5%) | (42.5%) | (22.2%) | (77.8%) | |
Have experienced adverse reactions after COVID-19 vaccination | |||||
 N´Ç | — | 4,203 | 2,757 | — | |
(60.4%) | (39.6%) | ||||
 Y±ð²õ | 1,497 | 1,577 | |||
(48.7%) | (51.3%) | ||||
Social Support, mean ± SD | 14.55 ±â¶Ä‰4.85 | 15.91 ±â¶Ä‰4.13 | 12.8 ±â¶Ä‰5.11 | 15.22 ±â¶Ä‰5.19 | 12.58 ±â¶Ä‰6.00 |